Literature DB >> 4178189

Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate.

W W Scott, J C Wade.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4178189     DOI: 10.1016/s0022-5347(17)62279-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  12 in total

1.  The ultrastructure of the accessory sex organs of the male rat. 7. The effect of an anti-androgenic compound, SK and F 22340.

Authors:  K J Tveter; E Dahl
Journal:  Urol Res       Date:  1975

2.  Effect of an antiandrogen on the lymphoid system.

Authors:  M Vojtísková; M Polácková; V Viklický
Journal:  Experientia       Date:  1976-09-15

Review 3.  Benign prostatic hyperplasia: the best treatment.

Authors:  G D Chisholm
Journal:  BMJ       Date:  1989-07-22

4.  Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.

Authors:  P Ostri; R Swartz; H H Meyhoff; J H Petersen; G Lindgård; C Frimodt-Møller; T Andersson; M S Nielsen
Journal:  Urol Res       Date:  1989

5.  Effects of cimetidine, progesterone, cannitracin and tolazoline on the weight and DNA content of the testosterone-induced hyperplastic prostate of the rat.

Authors:  W Chen; X M Zhou; D Y Chen; J S Kang
Journal:  Urol Res       Date:  1988

Review 6.  A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasia.

Authors:  P Ekman
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

7.  Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

8.  Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study.

Authors:  K M Jensen; P O Madsen
Journal:  Urol Res       Date:  1983

9.  Gestagens in the management of prostatic carcinoma.

Authors:  Z Szendröi
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

10.  Pharmacotherapy for benign prostatic hyperplasia.

Authors:  P Narayan; R Indudhara
Journal:  West J Med       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.